Is Axcella Health stock a good buy?

Axcella Health stock has received a consensus rating of buy. The average rating score is and is based on 7 buy ratings, 2 hold ratings, and 0 sell ratings. What was the 52-week low for Axcella Health stock? The low in the last 52 weeks of Axcella Health stock was 0.16.

What are the 12 month price objectives for Axcella Health (AXLA)?

4 Wall Street research analysts have issued 12 month price objectives for Axcella Health's shares. Their AXLA share price forecasts range from $2.00 to $8.00. On average, they predict the company's share price to reach $5.25 in the next year. This suggests a possible upside of 1,088.6% from the stock's current price.

How much did Axcella Health raise in an IPO?

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO. What is Axcella Health's stock symbol? Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

What did Axcella Therapeutics (AXLA) gain in premarket trading?

Shares of Axcella Therapeutics Inc. AXLA, +6.79% gained 10.9% in premarket trading on Thursday after the biotech said its experimental treatment for nonalcoholic steatohepatitis (NASH) showed statisti...